Lv1
70 积分 2025-10-13 加入
ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma
2个月前
已完结
CD40 Agonist Antibodies in Cancer Immunotherapy
2个月前
已关闭
Understanding and treating the inflammatory adverse events of cancer immunotherapy
2个月前
已关闭
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
3个月前
已关闭
Preclinical Evaluation of [¹⁷⁷Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate Cancer
3个月前
已完结
Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [68Ga]Ga/[177Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma
3个月前
已完结
The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations
7个月前
已完结
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
7个月前
已完结
Capmatinib Could Alter NSCLC Treatment Landscape
7个月前
已关闭
Evolving roles of MET as a therapeutic target in NSCLC and beyond
7个月前
已完结
皖公网安备34019202002308
